there are still concerns with weight gain after stopping these medications, so more research is needed in order to understand the main reasons for the weight gain. Research is now focused on trying to figure out more about how these drugs work
Given the documented risks associated with high-dose or long-term use of flavonoids, including hepatotoxicity, genotoxicity, endocrine disruption, gut microbiota dysbiosis, and drug interactions, it is imperative to develop optimized oral and topical delivery strategies
Emerging hormonal agents include selective progesterone receptor modulators (SPRMs) such as ulipristal acetate and mifepristone, which have shown promising results in ameliorating endometriosis-associated pain
Livadas S, Bothou C, Androulakis I, Boniakos A, Angelopoulos N, Duntas L
Our medical team will monitor your progress closely and adjust your treatment as needed for your safety and comfort